Trial site
Acclaim Clinical Research
- 15running trials
- 5closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Migraine3 trials
- Type 2 diabetes3 trials
- Atopic dermatitis (eczema)2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Chronic spontaneous urticaria1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Gastroparesis1 trial
- High blood pressure1 trial
- Liver cirrhosis1 trial
- Long COVID and ME/CFS1 trial
- and 3 more
- Phase
- Phase 313 trials
- Phase 26 trials
- Phase 1/21 trial
- Status
- Active, not recruiting8 trials
- Recruiting6 trials
- Completed5 trials
- Not yet recruiting1 trial
- Lead sponsor
- Amgen3 trials
- Boehringer Ingelheim3 trials
- TriGemX Bio, Inc.3 trials
- Celldex Therapeutics2 trials
- Eli Lilly and Company2 trials
- and 7 more
Running trials
Not yet recruiting
Recruiting
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Active, not recruiting
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Active, not recruiting
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes3 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Migraine2 recruiting
- Obesity2 recruiting
- High blood pressure1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026